GeoVax Labs Inc
NASDAQ:GOVX
GeoVax Labs Inc
NASDAQ:GOVX
Price:
1.34
USD
4.69%
Market Cap:
$3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
GeoVax Labs Inc
NASDAQ:GOVX
|
US |
|
C
|
Canada Goose Holdings Inc
NYSE:GOOS
|
CA |
|
W
|
Westinghouse Air Brake Technologies Corp
XBER:WB2
|
US |
|
Satyamitra Kemas Lestari Tbk PT
IDX:SMKL
|
ID |
|
S
|
Sercomm Corp
TWSE:5388
|
TW |
|
L
|
Lion Rock Resources Inc
XTSX:ROAR
|
CA |
|
Happy Valley Nutrition Ltd
ASX:HVM
|
NZ |
|
Xiamen C&D Inc
SSE:600153
|
CN |
|
C
|
CCFNB Bancorp Inc
OTC:CCFN
|
US |
|
Hamamatsu Photonics KK
TSE:6965
|
JP |
|
Freelance.com SA
PAR:ALFRE
|
FR |
|
T
|
Toshiba Tec Corp
TSE:6588
|
JP |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of GOVX.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GOVX
Multiples-Based Value
Not Available
Multiples Across Competitors
GOVX Competitors Multiples
GeoVax Labs Inc Competitors
GeoVax Labs Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
GeoVax Labs Inc
NASDAQ:GOVX
|
3m USD | 0.7 | -0.1 | 0.1 | 0.1 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.7B USD | 6 | 87.6 | 14.5 | 20.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.2 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.3 | 28.2 | 21.1 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD | 5.5 | 17.5 | 13 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR | 12.4 | 39.7 | 43.1 | 44 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD | 3 | 33 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
